D-2-Aminovaleric acid-benzyl ester 4-toluenesulfonate salt

Catalog No.: 
ACAZTI855
CAS No.: 
218962-76-6
Molecular Formula: 
C19H25NO5S
Molecular Weight: 
379.48
D-2-Aminovaleric acid-benzyl ester 4-toluenesulfonate salt structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$181.00InquiryInquiry
5g98%$663.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameD-2-Aminovaleric acid-benzyl ester 4-toluenesulfonate salt
IUPAC Namebenzyl 2-aminopentanoate 4-methylbenzenesulfonate
Molecular FormulaC19H25NO5S
Molecular Weight379.48
SMILESCC1=CC=C(S(=O)(=O)O)C=C1.CCCC(N)C(=O)OCC1=CC=CC=C1
InChI KeyAJFDJJVOIOXJFJ-UHFFFAOYSA-N
SynonymH-D-NVA-OBZL P-TOSYLATE;H-D-NVA-OBZL TOS-OH;D-NORVALINE BENZYL ESTER 4-TOLUENESULFONATE SALT;D-NORVALINE-OBZL P-TOSYLATE;D-2-AMINOVALERIC ACID-BENZYL ESTER 4-TOLUENESULFONATE SALT;D-2-AMINOVALERIC ACID-BENZYL ESTER P-TOSYLATE;H-D-Nva-OBzl;D-Norvaline benzyl ester 4-toluenesulfonate salt≥ 98% (HPLC)
CAS No.218962-76-6

Synthetic Route by SureRoute

1. ACAZTI855 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOAHL031 route compound structure diagram
    ACOAHL031760-78-1In Stock
  4. Then
  5. ACAZTI855 route product structure diagram
    ACAZTI855218962-76-6
Inquiry

2. ACAZTI855 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUHQC098 route compound structure diagram
    ACUHQC0986600-40-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAZTI855 route product structure diagram
    ACAZTI855218962-76-6
Inquiry

3. ACAZTI855 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAZTI855 route product structure diagram
    ACAZTI855218962-76-6
Inquiry

Comments (0)